Market & RegulationInvestment · $2.1B
DeepMind Spinout Isomorphic Labs Raises $2.1B
Siftedhigh confidence
Why it matters
- →Isomorphic Labs is leveraging AI to transform drug discovery, a field traditionally reliant on slower methods.
- →The $2.1 billion funding round indicates strong investor confidence in AI's potential to revolutionize pharmaceuticals.
- →Partnerships with major pharmaceutical companies suggest significant industry interest and potential for impactful collaborations.
Isomorphic Labs, a spinout from DeepMind, has raised $2.1 billion in a Series B funding round led by Thrive Capital. The round also saw participation from the UK’s Sovereign AI fund, Abu Dhabi’s MGX, Alphabet's GV, and Singapore’s Temasek. Founded in 2021, Isomorphic Labs is developing a drug discovery platform using AlphaFold technology to predict protein structures. The company has already partnered with pharmaceutical giants like Eli Lilly and Novartis and is advancing towards pre-clinical trials. This funding highlights the increasing role of AI in transforming drug discovery processes.
Read originalMore from Sifted
Market & Regulationagents
AI Agents Outpace European Regulation Efforts
AI agents are advancing at a speed that European regulators are struggling to match, creating a significant challenge for oversight. The rapid pace of AI innovation is outstripping the ability of regulators to implement effective controls, raising concerns about potential risks. This situation demands more agile and responsive regulatory frameworks to keep pace with technological advancements. As AI agents become increasingly autonomous and capable, the urgency for effective regulation becomes more pronounced. The current gap between innovation and regulation underscores the need for swift action to ensure safety and ethical standards in AI development.
Sifted
Researchresearch
ETH Zurich students create first Swiss humanoid robot
ETH Zurich students have engineered what they claim to be the first Swiss humanoid robot, marking a notable achievement in the country's robotics sector. This project exemplifies the innovative spirit and technical expertise of Swiss engineering students. The team is now actively seeking funding to further develop and potentially commercialize their humanoid creation. This endeavor not only showcases the students' capabilities but also positions Switzerland as an emerging contender in the global robotics arena.
